SAN MATEO, Calif., Jan. 19, 2017 -- Coupa Software (NASDAQ:COUP), a leader in cloud-based spend management, announced today that the company has reached another significant milestone by winning its first manufacturing customer in Germany, Paul HARTMANN AG. Based in Heidenheim, HARTMANN is a leading provider of medical and hygiene products with core expertise in wound treatment, incontinence care, infection prevention, surgical supplies and personal healthcare.
HARTMANN chose Coupa’s Source to Pay (S2P) solution to help streamline its procurement process. With S2P, the company will leverage Coupa’s cloud-based, unified system that connects sourcing to purchasing, purchasing to invoicing and invoicing to payment.
“We look forward to leveraging Coupa’s unified spend management system to help us simplify buying processes, enhance the user experience and provide greater spend transparency,” said Thomas-Garry Stiller, vice president of global procurement at Paul HARTMANN AG.
“HARTMANN will optimize its spend management processes with the Coupa solution, while its employees can remain focused on the challenges facing healthcare today,” said Rob Bernshteyn, CEO of Coupa.
About Coupa Software
Coupa Software (NASDAQ:COUP) is the cloud platform for business spend. We deliver “Value as a Service” by helping our customers maximize their spend under management, achieve significant cost savings and drive profitability. Coupa provides a unified, cloud-based spend management platform that connects hundreds of organizations representing the Americas, EMEA, and APAC with millions of suppliers globally. The Coupa platform provides greater visibility into and control over how companies spend money. Customers – small, medium and large – have used the Coupa platform to bring billions of dollars in cumulative spend under management. Learn more at www.coupa.com. Read more on the Coupa Blog or follow @Coupa on Twitter.
Media inquiries: Orlando De Bruce Coupa Software Global Public Relations [email protected] O (650) 485-8629


JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Italy Fines Apple €98.6 Million Over App Store Dominance
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 



